2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
LAKE FOREST, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced...
Vallon Pharmaceuticals Announces Closing of Initial Public Offering
PHILADELPHIA, PA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON) (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
VANCOUVER, CANADA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN /...
Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience
Higher dose cohorts demonstrated 100% overall response rate, resulting in substantial reduction in baseline corticosteroid use Dose-dependent reduction of CD6 expression...
Tauriga Sciences, Inc. Now Configured to Accept the Following Cryptocurrencies as Payment Options on Its E-Commerce Platform: Bitcoin (BTC), Etherium (ETH), Bitcoin Cash (BCH), Dai (DAI), and Litecoin (LTC)
Tauriga Sciences, Inc. Tauri-Gum Store: E-Commerce Checkout Page The Acceptance of Bitcoin, and These Other Select Cryptocurrencies, Will Improve the...
Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the...
Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
SOUTH JORDAN, Utah, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer...
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy
In addition to preservation of neurocognitive development with ABO-102 in MPS IIIA, new clinical results of ABO-102 in MPS IIIA...
Radius Health, Inc. Provides Abaloparatide Business Update
17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing averageHistomorphometry study published: Journal of Bone...
Delisting of AS „Grindeks” shares from the Baltic Main list
Delisting of AS „Grindeks” shares from the Baltic Main list Joint Stock Company “Grindeks” hereby informs that Nasdaq Riga decided...
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021
Bagsværd, Denmark, 12 February 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by...
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line
NEW YORK, NY , Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),...
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), a specialty life...
Sienna Announces February Dividend
MARKHAM, Ontario, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day
AUSTIN, TX & DURHAM, NC, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...
Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021
Conference Call and Webcast Scheduled for February 18, 2021, 4:30 pm ETPRINCETON, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Oyster...
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
EDISON, NJ / ACCESSWIRE / February 12, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) ("Hepion Pharmaceuticals" or the "Company") today announced...
Heat Biologics to Present at 2021 BIO CEO & Investor Digital Conference
DURHAM, NC / ACCESSWIRE / February 12, 2021 / Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), a clinical-stage biopharmaceutical company focused on...
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020
HILLSIDE, NJ / ACCESSWIRE / February 12, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial...
First-in-Class Biologic Eye Drop Regener-Eyes Launches “Mechanism of Action” Video Series
The new video series educates on the root causes of dry eye disease, and how Regener-Eyes® may provide some relief....